Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Get well soon Matt

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Jun 24, 2024 9:18am

114 Views

Post# 36102986

RE:RE:Get well soon Matt

Two maga extremists wearing red maga hats arrested for the rape and murder last night of a 13 yr. Old girl....when is the violence from this vicious faction going to be stopped? Absolutely disgusting!....

.....oh, wait.....no sorry.....they were just 2 convicted felons from Venezuela who were allowed into the country by Demautocrat open border policies......never mind....nothing to see here.....

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects